RnRmarketResearch.

com adds report Chemotherapy Induced Nausea and Vomiting Pipeline Review,
H2 2014 to its store.

Chemotherapy Induced Nausea and Vomiting Pipeline Review, H2 2014, provides an overview of the
Chemotherapy Induced Nausea and Vomitings therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Chemotherapy
Induced Nausea and Vomiting, complete with comparative analysis at various stages, therapeutics
assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule
type, along with latest updates, and featured news and press releases. It also reviews key players
involved in the therapeutic development for Chemotherapy Induced Nausea and Vomiting and special
features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Directs proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Directs team. Drug profiles/records featured in the
report undergoes periodic updation following a stringent set of processes that ensures that all the
profiles are updated with the latest set of information. Additionally, processes including live news &
deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent
developments are captured on a real time basis.

Complete report available @ http://www.rnrmarketresearch.com/chemotherapy-induced-nausea-andvomiting-pipeline-review-h2-2014-market-report.html .

The report enhances decision making capabilities and help to create effective counter strategies to gain
competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce
first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance
of data for the indicated disease.

Scope

The report provides a snapshot of the global therapeutic landscape of Chemotherapy Induced
Nausea and Vomiting
The report reviews key pipeline products under drug profile section which includes, product
description, MoA and R&D brief, licensing and collaboration details & other developmental
activities
The report reviews key players involved in the therapeutics development for Chemotherapy
Induced Nausea and Vomiting and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Chemotherapy Induced Nausea and Vomiting products under development by
companies and universities/research institutes based on information derived from company and
industry-specific sources
Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Chemotherapy Induced Nausea and Vomiting pipeline on the basis of target,
MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products

Reasons to buy

Provides strategically significant competitor information, analysis, and insights to formulate

effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for
Chemotherapy Induced Nausea and Vomiting
Plan mergers and acquisitions effectively by identifying key players of the most promising
pipeline
Devise corrective measures for pipeline projects by understanding Chemotherapy Induced
Nausea and Vomiting pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners
with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the
factors that drove them from pipeline

Inquire for Discount @ http://www.rnrmarketresearch.com/contacts/discount?rname=248280 .

(This is a premium report priced at US$2000 for a single user PDF.)

List of Tables

Number of Products under Development for Chemotherapy Induced Nausea and Vomiting, H2 2014 9
Number of Products under Development for Chemotherapy Induced Nausea and Vomiting Comparative Analysis, H2 2014 10
Number of Products under Development by Companies, H2 2014 12
Comparative Analysis by Late Stage Development, H2 2014 13
Comparative Analysis by Clinical Stage Development, H2 2014 14
Comparative Analysis by Early Stage Development, H2 2014 15
Comparative Analysis by Unknown Stage Development, H2 2014 16
Products under Development by Companies, H2 2014 17
Chemotherapy Induced Nausea and Vomiting - Pipeline by Acacia Pharma Ltd., H2 2014 18
Chemotherapy Induced Nausea and Vomiting - Pipeline by Aphios Corporation, H2 2014 19
Chemotherapy Induced Nausea and Vomiting - Pipeline by BioDelivery Sciences International, Inc., H2
2014 20
Chemotherapy Induced Nausea and Vomiting - Pipeline by Genovate Biotechnology Co., LTD., H2 2014
21
Chemotherapy Induced Nausea and Vomiting - Pipeline by Helsinn Holding S.A., H2 2014 22
Chemotherapy Induced Nausea and Vomiting - Pipeline by Heron Therapeutics, Inc., H2 2014 23
Chemotherapy Induced Nausea and Vomiting - Pipeline by INSYS Therapeutics, Inc., H2 2014 24
Chemotherapy Induced Nausea and Vomiting - Pipeline by Kyowa Hakko Kirin Co., Ltd., H2 2014 25
Chemotherapy Induced Nausea and Vomiting - Pipeline by Merck & Co., Inc., H2 2014 26
Chemotherapy Induced Nausea and Vomiting - Pipeline by RedHill Biopharma Ltd., H2 2014 27
Chemotherapy Induced Nausea and Vomiting - Pipeline by Shin Nippon Biomedical Laboratories, Ltd., H2
2014 28

Chemotherapy Induced Nausea and Vomiting - Pipeline by Suda Ltd, H2 2014 29

Chemotherapy Induced Nausea and Vomiting - Pipeline by Teikoku Pharma USA, Inc., H2 2014 30
Chemotherapy Induced Nausea and Vomiting - Pipeline by Tesaro, Inc., H2 2014 31
Assessment by Monotherapy Products, H2 2014 32
Assessment by Combination Products, H2 2014 33
Number of Products by Stage and Target, H2 2014 35
Number of Products by Stage and Mechanism of Action, H2 2014 37
Number of Products by Stage and Route of Administration, H2 2014 39
Number of Products by Stage and Molecule Type, H2 2014 40
Chemotherapy Induced Nausea and Vomiting Therapeutics - Recent Pipeline Updates, H2 2014 64
Chemotherapy Induced Nausea and Vomiting - Dormant Projects, H2 2014 77
Chemotherapy Induced Nausea and Vomiting - Discontinued Products, H2 2014 78

Purchase a copy of this report @

http://www.rnrmarketresearch.com/contacts/purchase?rname=248280 .

About Us:
RnRmarketResearch.com is your single source for all market research needs. Our database includes
450,000+ market research reports from over 95 leading global publishers & in-depth market research
studies of over 5000 micro markets. We offer you customization options on reports by & custom reports
through MarketsandMarkets.com. With comprehensive information about the publishers and the
industries for which they publish market research reports, we help you in your purchase decision by
mapping your information needs with our huge collection of reports.